MSF Science Portal
My saved items
Conference Material > Video
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial
Solomos A
Share
Linked Items
Share
Video
Countries
Ethiopia
Kenya
Uganda
Sudan
Subject Area
neglected tropical diseases
kala azar
DOI
10.57740/a51f-3605
Published Date
07-Jun-2023
Languages
English
Conference
MSF Scientific Day International 2023
Linked Items
Conference Material > Slide Presentation
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial
07-Jun-2023
Conference Material > Abstract
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial
07-Jun-2023
